Total Payments
$1,527
2024 Payments
$222.83
Companies
13
Transactions
93
Medicare Patients
10,304
Medicare Billing
$16.9M
Payment Breakdown by Category
Food & Beverage$1,513 (99.1%)
Education$14.13 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,513 | 92 | 99.1% |
| Education | $14.13 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $705.81 | 54 | $0 (2024) |
| Allergan, Inc. | $170.78 | 6 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $170.65 | 9 | $0 (2024) |
| ABBVIE INC. | $117.15 | 5 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $107.34 | 7 | $0 (2019) |
| Ocular Therapeutix, Inc. | $50.00 | 1 | $0 (2024) |
| TearLab Corp | $45.86 | 2 | $0 (2017) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $45.11 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $33.56 | 2 | $0 (2021) |
| Alimera Sciences, Inc. | $30.79 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $222.83 | 8 | ABBVIE INC. ($77.57) |
| 2023 | $92.77 | 5 | Regeneron Healthcare Solutions, Inc. ($37.15) |
| 2022 | $106.26 | 8 | Genentech USA, Inc. ($68.26) |
| 2021 | $100.57 | 6 | Genentech USA, Inc. ($32.72) |
| 2020 | $129.51 | 8 | Genentech USA, Inc. ($68.32) |
| 2019 | $304.10 | 15 | Genentech USA, Inc. ($145.11) |
| 2018 | $269.33 | 18 | Genentech USA, Inc. ($197.15) |
| 2017 | $302.09 | 25 | Genentech USA, Inc. ($141.29) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Ocular Therapeutix, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 11/14/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $33.21 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: EYE CARE | ||||||
| 07/10/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: EYE CARE | ||||||
| 05/28/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: EYE CARE | ||||||
| 02/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/29/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $21.01 | General |
| 08/24/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/28/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/20/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/19/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/30/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/30/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $0.48 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/22/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/19/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/06/2022 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $13.74 | General |
| 09/08/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: RETINA | ||||||
| 02/23/2022 | Genentech USA, Inc. | SUSVIMO (Drug), VABYSMO | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/23/2022 | Genentech USA, Inc. | SUSVIMO (Drug), VABYSMO | Food and Beverage | In-kind items and services | $2.42 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/30/2021 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $16.56 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/31/2021 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/05/2021 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Ophthalmology | ||||||
| 07/19/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: RETINA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,614 | 24,459 | $11.9M | $4.0M |
| 2022 | 13 | 2,411 | 15,466 | $10.0M | $3.7M |
| 2021 | 15 | 2,732 | 20,219 | $11.9M | $4.7M |
| 2020 | 11 | 2,547 | 18,392 | $10.7M | $4.4M |
Total Patients
10,304
Total Services
78,536
Medicare Billing
$16.9M
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 311 | 4,202 | $6.3M | $2.9M | 46.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 20 | 11,700 | $1.3M | $337,721 | 26.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 115 | 1,547 | $780,700 | $281,746 | 36.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 378 | 2,129 | $2.2M | $199,114 | 9.2% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 21 | 520 | $704,480 | $112,972 | 16.0% |
| 92134 | Imaging of retina | Office | 2023 | 768 | 2,859 | $214,173 | $80,608 | 37.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 388 | 691 | $117,470 | $42,967 | 36.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 383 | 533 | $127,800 | $42,319 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 151 | 151 | $47,680 | $16,892 | 35.4% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 14 | 14 | $91,756 | $12,065 | 13.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 14 | 44 | $6,600 | $2,308 | 35.0% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 21 | 22 | $5,676 | $2,153 | 37.9% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 17 | 32 | $13,056 | $1,062 | 8.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 13 | 15 | $1,905 | $620.23 | 32.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 193 | 2,480 | $3.7M | $1.8M | 47.7% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 200 | 6,884 | $3.4M | $1.5M | 44.5% |
| 67028 | Injection of drug into eye | Office | 2022 | 379 | 2,138 | $2.2M | $195,311 | 9.0% |
| 92134 | Imaging of retina | Office | 2022 | 776 | 2,861 | $214,287 | $78,627 | 36.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 306 | 376 | $84,715 | $29,679 | 35.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 261 | 387 | $61,525 | $22,656 | 36.8% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2022 | 20 | 20 | $137,003 | $17,428 | 12.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 160 | 160 | $41,753 | $14,922 | 35.7% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2022 | 14 | 15 | $98,310 | $12,316 | 12.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $14,560 | $5,742 | 39.4% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 20 | 62 | $9,300 | $3,163 | 34.0% |
About Dr. John Payne, MD
Dr. John Payne, MD is a Ophthalmology healthcare provider based in West Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528143021.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Payne, MD has received a total of $1,527 in payments from pharmaceutical and medical device companies, with $222.83 received in 2024. These payments were reported across 93 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,513).
As a Medicare-enrolled provider, Payne has provided services to 10,304 Medicare beneficiaries, totaling 78,536 services with total Medicare billing of $16.9M. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location West Columbia, SC
- Active Since 10/25/2006
- Last Updated 04/03/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1528143021
Products in Payments
- Lucentis (Biological) $584.59
- OZURDEX (Drug) $272.61
- ACTHAR (Biological) $107.34
- EYLEA (Biological) $98.03
- Vabysmo (Drug) $52.96
- VABYSMO (Drug) $49.67
- TearLab Osmolarity System (Device) $45.86
- EYLEA AFLIBERCEPT INJECTION (Biological) $39.41
- BEOVU (Drug) $33.56
- EYLEA HD (Biological) $33.21
- VISUDYNE (Drug) $22.59
- LOTEMAX SM (Drug) $22.52
- SUSVIMO (Drug) $18.59
- ILUVIEN (Drug) $16.56
- LOTEMAX GEL (Drug) $15.66
- Humira (Biological) $15.32
- Iluvien (Drug) $14.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in West Columbia
William Clark, Md, MD
Ophthalmology — Payments: $1.0M
Ophthalmology $1.0M
John Wells, Md, MD
Ophthalmology — Payments: $38,502
Ophthalmology $38,502
Bethany Bray, M.d, M.D
Ophthalmology — Payments: $11,414
Ophthalmology $11,414
Teresa Fowler, Md, MD
Ophthalmology — Payments: $4,971
Ophthalmology $4,971
Nitin Nigam, Md, MD
Ophthalmology — Payments: $1,378
Ophthalmology $1,378
David Johnson, Md, MD
Ophthalmology — Payments: $1,034
Ophthalmology $1,034